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Abstract The Src family protein-tyrosine kinases (PTKs) are 
known to be important for B cell antigen receptor (BCR) signal- 
ing. To study the mechanism of action of Src-PTK in BCR 
signaling, kinase deficient- and Src homology 2 (SH2)-mutants 
of Src-PTK were transfected into Lyn-deficient B cells and ana- 
lyzed. Kinase activity of Src-PTK was essential for tyrosine phos- 
phorylation of Syk and calcium mobilization upon receptor liga- 
tion, whereas these events were not affected by the mutation of 
SH2 domain. Receptor-mediated tyrosine phosphorylation of 
Lyn was still observed in Syk-deficient B cells. These results 
demonstrate that the BCR-induced phosphorylation of Src-PTK 
is independent of Syk and that the kinase activity of Src-PTK is 
critical for BCR signaling. 
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showed that Fyn or Lyn interacts with resting BCR primarily 
through the non-phosphorylated Iga chain Immunoreceptor 
Tyrosine based Activation Motif (ITAM) (low-affinity binding) 
and that tyrosine-phosphorylated Igc~ITAM induces the bind- 
ing to Fyn SH2 domain (high-affinity binding), leading to the 
increased kinase activity of Fyn [8]. However, the in vivo role 
of the Src-PTK SH2 domain in BCR signaling process has not 
been established. Moreover, it has not been clearly demon- 
strated that the kinase activity of Src-PTK plays a role in 
receptor signaling. 
To address the in vivo functions of Src-PTK domains in 
regulating BCR signal transduction, we mutated residues re- 
quired for SH2 or kinase function of Src-PTK and analyzed the 
ability of these constructs to restore BCR signaling. In this 
report, we demonstrate hat the catalytic activity of Src-PTK 
is essential for BCR signaling and suggest that the SH2 domain 
of Src-PTK is not crutical for early signaling events. 
1. Introduction 2. Materials and methods 
Induced phosphorylation f several proteins on tyrosine res- 
idues is the earliest biochemical event detectable upon B cell 
antigen receptor (BCR) stimulation [1,2]. The BCR associates 
with two classes of tyrosine kinases; Src-family protein tyrosine 
kinase (PTK) and Syk kinase. These PTKs become activated 
as a result of receptor cross-linking. The activation of these 
kinases leads to rapid tyrosine phosphorylation f several pro- 
teins including the BCR Iga, Igfl chains, phosphatidylinositol 
(PI)-3 kinase, p21r'-GTPase activating protein (GAP), VAV, 
and phospholipase C (PLC)-z2 [3,4]. 
The importance ofSrc-PTKs in BCR signaling isemphasized 
by the finding that mutant B cell clones devoid of Lyn respond 
to BCR stimuli with a very limited tyrosine phosphorylation f 
cellular substrates [5]. Activity of Src-PTKs can be regulated 
by tyrosine phosphorylation. There are two known sites of 
regulation: a positive regulatory autophosphorylation site, and 
a C-terminal tyrosine, asite of negative regulation. Phosphoryl- 
ation at the negative regulatory site is believed to maintain the 
enzyme in an inactive conformation by an intramolecular inter- 
action with the Src homology 2 (SH2) domain of the kinase 
[6,7]. 
In addition to regulation of Src-PTK by phosphorylation, it 
is proposed that a spatial reorientaion of Src-PTK alters its 
kinase activity during BCR stimulation. In vitro binding data 
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2.1. Cell culture, DNA transjeetion, and antisera 
Chicken wildtype DT40 cells and various mutant cells were cultured 
in RPMI 1640 supplemented with 10% fetal calf serum. Kinase-defi- 
cient and SH2-mutant cDNAs of mouse fyn (Lys 2~6 to Met 296 and 
Arg176-Glu177-Ser 178 to Asp176-Glu177-Cys178, respectively) [9]were cre- 
ated by polymerase chain reaction and was cloned into pApuro vector 
[5]. Resulting constructs were confirmed by DNA sequencing. These 
cDNAs were transfected intolyn-negative DT40 cells [5] by electropo- 
ration using Gene pulser apparatus (Bio-Rad Laboratories) at 550 V, 
25 p F, and selected inthe presence of 0.5 pg/ml puromycin. Expression 
of mutated Fyn was assessed by immunoblotting. 
The mAb M4, an anti-chicken IgM, was used for stimulation of BCR 
on DT40 cells [10]. Abs against chicken Ly  and Syk were already 
described [5]. Abs against phosphotyrosine (4GI0) and Fyn were pur- 
chased from Upstate Biotechnology and Oncogene Sciences, respec- 
tively. 
2.2. Immunoprecipitation analysis 
In experiments shown in Figs. 1, 4 and 6, cells were solubilized in 
NP-40 lysis buffer (1% NP-40, 150 mM NaC1, 20 mM Tris, pH 7.5, 
1 mM EDTA) containing 50 mM NaF, 10/IM molybdate, 0.2 mM 
Na3VO4 supplemented with protease inhibitors as described in [11]. 
Insoluble material was removed by centrifugation  12,000 x g for 10 
min. These clarified lysates were incubated sequentially (1 h, 4 °C for 
each incubation) with Abs and protein A-Sepharose. The immunopre- 
cipitates were washed four times with lysis buffer. Whole cell lysates 
shown in Fig. 3, were prepared from non-stimulated or M4-stimulated 
DT40 cells using SDS sample buffer. Whole cell lysates or immunopre- 
cipitates were fractionated on 8%SDS-PAGE and transferred to nitro- 
cellulose. The blots were blocked with 5% milk in 25 rnM Tris (pH 7.9), 
150 mM NaCI with 0.05% Tween-20, and incubated with primary Ab 
for 1 h at room temperature. Filters were developed with a goat anti- 
mouse or donkey anti-rabbit secondary Ab conjugated to horseradish 
peroxidase using the Enhanced Chemiluminescence (ECL) detection 
system (Amersham). 
For in vitro kinase assay, the immunoprecipitates were washed with 
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Fig. 1. Expression of mutant Fyn in Lyn-deficient DT40 cells. DT40 cells (0.5 x 10 6 cells/lane) expressing i dicated constructs were lysed with NP-40 
buffer and electrophoresed on a 8% SDS-PAGE, transferred to nitrocellulose, and immunoblotted using anti-Fyn Ab (A). NP-40 lysates (2 x 106 
cells/lane) were immunoprecipitated by anti-Fyn Ab, divided, and half of them were used for in vitro kinase assay (top in B). The remaining half 
were used for Western blotting with anti-Fyn Ab (bottom in B). 
kinase buffer (20 mM Tris, pH 7.4, 10 mM MnCI2) after washing with 
lysis buffer. The immunoprecipitates were then suspended in 30/zl of 
kinase buffer with 1 /tM ATP and 10/tCi of [7"-32p]ATP (3,000 Ci/ 
mmol), and the kinase reaction was carried out at 30°C for 10 min. 
2.3. Calcium obilization and fluorescence-activated cell sorter ( FA CS) 
analysis 
Measurements of intracellular free calcium were performed using 
fura-2/AM. Cells (5 × 106/m]) were washed once and loaded with 3/.tM 
fura-2/AM in PBS containing 20 mM HEPES (pH 7.2), 5 mM glucose, 
0.025% BSA and 1 mM CaC12. After incubation for 45 min at 37 °C, 
cells were washed twice and diluted to 106 cells/ml. Fluorescence ofcell 
suspension was continuously monitored with a fluorescence spectro- 
photometer Hitachi F-2000 at an excitation wavelength of 340 nm and 
an emission wavelength of510 nm. [Ca2+]~ was calibrated and computed 
as described in [12]. 
For FACS analysis, DT40 cells were washed, subsequently incubated 
with FITC-conjugated anti-chicken IgM (Bethyl Laboratories), and 
analyzed using a FACSort (Becton Dickinson). 
3. Results 
We previously showed that the function of Lyn is compen- 
sated by other Src-PTKs, Fyn and Lck [5]. To study the func- 
tional importance of the SH2 domain and catalytic activity of 
Src-PTK in BCR signaling, we prepared mutants of Fyn that 
were defective in phosphotyrosine-binding site of the SH2 do- 
main (Arg176-Glu177-Ser178 to Aspi76-Glu177-Cyst78; mSH2) and 
phosphotransferase activity (Lys 296 to Met296; K-), and ex- 
pressed these in Lyn-deficient DT40 B cells. The expression of 
mutated Fyn was monitored by immunoblotting and in vitro 
kinase assay (Fig. 1A and B). Even though the amount of 
immunoprecipitated Fyn(mSH2) was almost same as that of 
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Fig. 2. Cell surface expression of BCR on DT40 cells. Transfected 
DT40 cells were stained with FITC-labeled anti-chicken IgM. Un- 
stained cells are the negative control in each case. 
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Fig. 3. Tyrosine phosphorylation f whole cell proteins following BCR stimulation. At the indicated times following the addition of M4 (4/lg/ml), 
whole cell lysates were prepared from 2.5 x 106 cells and loaded on a 8% SDS-PAGE. After transfer to nitrocellulose, the pbosphotyrosine containing 
proteins were detected byimmunoblotting with anti-phosphotyrosine mAb 4G10. 
wildtype Fyn, autophosphorylation magnitude of Fyn(mSH2) 
was about 2-fold lower than that of wildtype Fyn. Phosphoryl- 
ation activity for an exogenus ubstrate nolase was also de- 
creased by this SH2 mutation (data not shown). Cell surface 
expression of BCR on these transfectants was assayed by 
FACS, and demonstrated ssentially the same l vel as wildtype 
DT40 and Lyn-deficient cells (Fig. 2). 
Tyrosine phosphorylation of cellular proteins was analyzed 
by anti-phosphotyrosine immunoblotting of extracts from Lyn- 
deficient DT40 cells expressing Fyn(wt), Fyn(mSH2), and 
Fyn(K-), following anti-BCR mAb cross-linking (Fig. 3), While 
Fyn(wt) showed the similar phosphorylation pattern to 
wildtype DT40 cells, Fyn(K-) exhibited almost same pattern as 
parental Lyn-deficient DT40 cells, indicating the requirement 
of the kinase activity of Src-PTK for BCR-induced global tyro- 
sine phosphorylation. Although Fyn(mSH2) showed the de- 
creased in vitro kinase activity (Fig. 1B), tyrosine phosphoryla- 
tion in DT40 cells expressing Fyn(mSH2) at the resting state 
was somewhat increased, compared with that of Fyn(wt). Nev- 
ertheless, tyrosine phosphorylation f 40-, 78-, 90-kDa proteins 
was clearly induced upon receptor crosslinking in DT40 cells 
expressing Fyn(mSH2). 
Anti-pY 
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Fig. 4. Tyrosine phosphorylation f Syk after BCR stimulation. Cells were stimulated as described in Fig. 3 legend, lysed b  NP-40 buffer, 
immunoprecipitated with an i-Syk Ab. Samples were loaded on a 8% SDS-PAGE, transferred to nitrocellulose, incubated with anti-phosphotyrosine 
mAb 4G10 (upper). After filters were stripped, thesame blots were reprobed with anti-Syk Ab (bottom). 
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Fig. 5. Calcium mobilization upon BCR stimulation of DT40 cells. 
Cells were loaded with fura-2/AM, and the samples (1 × 10 6 cells/ml) 
were stimulated with M4 (1 ,ug/ml). As a control, cells were stimulated 
with thapsigargin (10/tg/ml), yielding similar amount of calci m mobi- 
lization in all clones. 
One potential substrate of Src-PTK in the context of BCR 
signaling is Syk [13]. Thus, the effect of kinase activity and SH2 
domain of Fyn on BCR-induced phosphorylation f Syk was 
examined by immunoprecipitation of Syk from cells expressing 
Fyn(wt), Fyn(K-), and Fyn(mSH2), followed by immunoblot- 
ting with anti-phosphotyrosine mAb (Fig. 4). Fyn(K-) was in- 
capable of phosphorylating Syk, consistent with the overall 
tyrosine phosphorylation pattern in DT40 cells expressing this 
mutant (Fig. 3). In cells expressing Fyn(wt) and Fyn(mSH2), 
phosphorylation f Syk was induced upon receptor cross-link- 
ing, indicating that the SH2 domain of Src-PTK is not essential 
for BCR-induced phosphorylation f Syk. 
The conclusion that the kinase activity of Src-PTK, not SH2 
domain, is required for BCR-induced early signaling events was 
further confirmed by receptor-induced calcium mobilization 
data (Fig. 5). Fyn(mSH2) evoked the normal calcium mobiliza- 
tion upon BCR stimulation, whereas Fyn(K-) exhibited the 
similar calcium mobilization pattern to that of Lyn-deficient 
cells. 
To test the proposed idea that Syk acts as a kinase upstream 
of Src-PTKs in antigen receptor signaling [14], we examined the 
BCR-mediated tyrosine phosphorylation of Lyn in wildtype 
and Syk-deficient DT40 cells. As shown in Fig. 6, tyrosine 
phosphorylation f Lyn in wildtype DT40 cells was sligtly in- 
duced after 1 min stimulation of M4. This BCR-induced phos- 
phorylation was not significantly affected by the absence of 
Syk. These results uggest that the BCR-induced phosphoryla- 
tion of Lyn is independent of Syk. 
4. Discussion 
Numerous tudies have defined the importance of Src-PTK 
expression i  regulating an essential component(s) in the signal 
transduction pathway utilized by antigen receptors [3,4]. In 
Lyn-deficient B cells [5] and Lck-deficient T cells [15], signals 
emanating from the stimulated BCR and T cell antigen receptor 
(TCR) appear to be blocked at an early stage in the signaling 
pathway. This BCR-mediated responses can be restored by 
introducing another Src-PTK, Fyn or Lck [5], indicating some 
functional redundancy among Src-PTK family, at least in early 
signaling events. 
Mutation of SH2 domain of Fyn caused a decrease in tyro- 
sine kinase activity in vitro (Fig. 1B). However, this SH2 muta- 
tion increased phosphotyrosine-containing proteins at the rest- 
ing state of DT40 cells (Fig. 3). These results are in good 
agreement with the previous report that deletion of the SH2 
domain of Lyn causes an increase in tyrosine phosphorylation 
in NIH 3T3 cells despite its lower in vitro kinase activity [16]. 
In contrast o the lower kinase activity of the SH2 mutants of 
Fyn and Lyn, mutations in Src SH2 domain lead to the dra- 
matic increase in kinase activity [17,18]. These observations 
suggest that the enzymatic regulation of Fyn and Lyn is differ- 
ent from that of Src, and that the SH2 domain of Fyn and Lyn 
may play a role in repressing the ability of Fyn and Lyn to 
phosphorylate substrates through a mechanism independent of
regulating intrinsic kinase activity of Fyn and Lyn. 
It was proposed that tyrosine-phosphorylated Igc~ ITAM 
Anti-pY 
DT40 
0 1 3 
syk  - 
0 1 3 (min) 
-4  
Anti-Lyn 
Fig. 6. BCR-induced tyrosine phosporylation of Ly . Cells were stimu- 
lated as Fig. 3 legend, lysed by NP-40 buffer, immunoprecipitated with 
anti-Lyn Ab. Samples were divided and half were used for anti- 
phosphotyrosine immunoblotting using 4G10 (upper). Remaining im- 
munoprecipitates were used for immunoblotting ofLyn (bottom). 
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induces the binding to Fyn SH2 domain (high-affinity binding), 
leading to the increased kinase activity of Fyn in BCR signaling 
process [8]. However, BCR-induced calcium mobilization and 
phosphorylation of Syk were not affected by the SH2 mutation 
of Src-PTK. Thus our results suggest hat initial low-affinity 
binding of Src-PTK with non-phosphorylated Ig~ is sufficient 
for activating Src-PTK upon receptor cross-linking. The associ- 
ation of Lyn with BCR complex after receptor stimulation is 
readily disrupted by Nonidet P-40 [19], further supporting that 
Src-PTK is attached to the BCR complex through amechanism 
independent of phosphotyrosine-SH2 domain interaction. 
In the current study, we demonstrate that Src-PTK must 
have intact kinase activity for signal transduction through 
BCR. Induction of cellular tyrosine phosphoproteins in cells 
expressing Fyn(K-) was almost the same as that in Lyn-defi- 
cient cells (Fig. 3). Moreover, in these cells, Syk was not 
phosphorylated by receptor stimulation (Fig. 4), indicating the 
requirement of catalytic activity of Src-PTK for BCR-induced 
phosphorylation of Syk in B cells. Since Syk associates with 
Src-PTK, particularly Lyn, in B cells and in vitro [20], phospho- 
rylation of Syk by Src-PTK appears to be direct. The Src-PTK- 
mediated phosphorylation f Syk is about 5-fold reduced by the 
mutation of the putative autophosphorylation sites of Syk 
(Y518/519 to F518/519), indicating that these sites are one of 
the phosphorylation sites of Syk by Src-PTK in the context of 
BCR signaling [21]. Phosphorylation of the homologous tyro- 
sine of ZAP-70 (a PTK related to Syk which is expressed in 
T cells and NK cells) is shown to increase its kinase activity 
using purified ZAP-70 [22]. Taken together, these observations 
strengthen the proposal that the Src-PTK associated with BCR 
phosphorylates Syk, enhancing the activity of Syk in BCR 
signaling process. 
Two models have been proposed to describe the mechanistic 
activation of BCR or TCR. In the first, the Src-PTKs phospho- 
rylate the tyrosine residues in the ITAM of BCR or TCR 
subunits which in turn recruit Syk/ZAP-70 in a SH2- 
phosphotyrosine d pendent manner. Association of Syk/ZAP- 
70 to the antigen receptor esults in their phosphorylation by 
Src-PTKs, permitting phosphorylation of additional down- 
stream substrates [23]. A second model has been proposed in 
which Syk is constitutively associated with BCR or TCR and 
functions to activate the Src-PTKs [24]. Based on the latter 
model, Syk is autophosphorylated upon receptor ligation, per- 
mitting the recruitment of Src-PTKs via a SH2-phosphoty- 
rosine dependent manner. Indeed it was demonstrated that SH2 
domain of Src-PTK binds to the phosphorylated Syk/ZAP-70 
in vitro [14,25]. Data presented in this paper are more con- 
sistent with the first model. Although Src-PTK-dependent 
phosphorylation of Syk is dramatic in BCR signaling [13], Syk 
did not affect phosphorylation state of Lyn (Fig. 6). Further- 
more, in contrast o the functional importance of both SH2 
domains of Syk in receptor signaling [21], Src-PTK SH2 do- 
main did not affect early signaling events. Recent studies de- 
monstrating that activation of Src-PTKs temporally proceed 
the activation of Syk/ZAP-70 provide additional support for 
the first model [26]. 
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